CNS targeting of some novel 4 thiazolidinone derivatives as SIRT3 activators for the treatment of Parkinsons disease

Files

01_title.pdf (446.9 KB)

02_certificates.pdf (205.39 KB)

03_acknowledgment.pdf (33.24 KB)

04_contents.pdf (50.1 KB)

05_preface.pdf (90.47 KB)

Abstract

Available

URI

http://hdl.handle.net/10603/516075

Collections

College of Pharmacy